Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Colorcon
McKinsey
Merck
Cipla
Medtronic
Chubb
Fuji
McKesson
UBS

Generated: January 21, 2018

DrugPatentWatch Database Preview

Prednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone acetate and what is the scope of prednisolone acetate patent protection?

Prednisolone acetate
is the generic ingredient in eighteen branded drugs marketed by Schering, Akorn, Bel Mar, Cent Pharms, Watson Labs, Pfizer, Alcon, Novartis Pharms Corp, Allergan, Taro, Pharmafair, Novartis, and Bausch And Lomb, and is included in twenty-seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Prednisolone acetate has thirty-three patent family members in fourteen countries.

There are eighty-six drug master file entries for prednisolone acetate. Eleven suppliers are listed for this compound.
Summary for prednisolone acetate
Pharmacology for prednisolone acetate

US Patents and Regulatory Information for prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Allergan BLEPHAMIDE S.O.P. prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087748-001 Dec 3, 1986 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PREDNISOLONE ACETATE prednisolone acetate INJECTABLE;INJECTION 085781-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PREDNISOLONE ACETATE prednisolone acetate INJECTABLE;INJECTION 083654-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alcon CETAPRED prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087771-001 Aug 6, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering METICORTELONE prednisolone acetate INJECTABLE;INJECTION 010255-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan PRED MILD prednisolone acetate SUSPENSION/DROPS;OPHTHALMIC 017100-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alcon ECONOPRED prednisolone acetate SUSPENSION/DROPS;OPHTHALMIC 017468-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Schering METIMYD prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 010210-002 Sep 9, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ➤ Subscribe ➤ Subscribe
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Subscribe ➤ Subscribe
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ➤ Subscribe ➤ Subscribe
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for prednisolone acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,461,139 Oral suspension of prednisolone acetate ➤ Subscribe
6,355,258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form ➤ Subscribe
8,206,727 Oral suspension of prednisolone acetate ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for prednisolone acetate

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Deloitte
Novartis
Farmers Insurance
Cantor Fitzgerald
Covington
Argus Health
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot